Author

N. M. Corcoran

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Assay:DNA methylation· 1

Frequent Co-Authors

C. M. Hovens· 2 shared A. Gusev· 1 shared A. J. Costello· 1 shared A. T. Papenfuss· 1 shared A. U. Kishan· 1 shared B. J. Pope· 1 shared B. Pasaniuc· 1 shared C. Bell· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. M. Hovens

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Germline determinants of the prostate tumor genome

K. E. Houlahan, J. Yuan, T. Schwarz, J. Livingstone, N. S. Fox, W. Jaratlerdsiri, J. van Riet, K. Taraszka, N. Kurganovs, H. Zhu, J. Sietsma Penington, C.-H. Jung, T. N. Yamaguchi, J. Jiang, L. E. Heisler, , P. C. Boutros

The paper identifies germline-determined quantitative trait loci (dQTLs) that influence somatic mutational features in prostate cancer, revealing their impact on tumor epigenome, transcriptome, and proteome.

bioRxiv · Nov 16, 2022 · PreprintCancer Biology

SVclone: inferring structural variant cancer cell fraction

M. Cmero, C. S. Ong, K. Yuan, J. Schröder, K. Mo, PCAWG Evolution and Heterogeneity Working Group, N. M. Corcoran, A. T. Papenfuss, C. M. Hovens, F. Markowetz, G. Macintyre

SVclone infers cancer cell fractions of structural variant breakpoints from whole-genome sequencing data and identifies subclonal copy-number neutral rearrangements linked to decreased survival in certain cancers.

Nature Communications · Feb 5, 2020Peer-reviewedCancer Biology